Article · 28 Jun 2025
Similar by topic
Editorial · 31 Mar 2025
PCSK9 Inhibitors: A Novel Approach to Cholesterol Management and Atherosclerosis Prevention
Review article · 27 Jul 2023
Atherosclerosis: Targeting LDL Cholesterol with Statins and PCSK9 Inhibitors for Cardiovascular Disease Management
Editorial · 30 Mar 2020
Heart Congress 2019: It?s time to focus on decreasing cardiovascular mortality in NAFLD population: potential use of statins and PCSK9 inhibitors - Issues with Management - Tarek Ajam - Saint Louis University Saint Louis, MO, USA
Conference abstract · 10 Jul 2018
FOURIER STUDY for new lipid lowering injectable drug PCSK9 INHIBITORS.
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Advances in Antiplatelet Therapy for Secondary Prevention of Myocardial Infarction
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Wilbert S Aronow”

